WUXI BIO(02269)
25.500-0.850-3.23%
Login to post
- CommunityCommunity
- NewsNews
- ProfileProfile
- AnnouncementsAnnouncements
- WuXi Biologics (Cayman) Inc. (HKG:2269) Stocks Shoot Up 28% But Its P/E Still Looks ReasonableWuXi Biologics (Cayman) Inc. (HKG:2269) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable
Simply Wall St. · 03-16
- Greater China Stocks Close Mixed; Hong Kong Leads GainersGreater China Stocks Close Mixed; Hong Kong Leads Gainers
Dow Jones · 03-14
- WuXi Biologics Included in S&P Global Sustainability Yearbook 2025WuXi Biologics Included in S&P Global Sustainability Yearbook 2025
THOMSON REUTERS · 03-11
- WuXi Biologics (Cayman) Inc.'s (HKG:2269) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Simply Wall St. · 03-04
WuXi Biologics (Cayman) Inc.'s (HKG:2269) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? - Greater China Stocks Slip; Taiwan Sees Largest DeclineGreater China Stocks Slip; Taiwan Sees Largest Decline
Dow Jones · 02-24
- Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$30.59 From HK$19.30, Keeps at BuyNomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$30.59 From HK$19.30, Keeps at Buy
MT Newswires Live · 02-20
- WuXi Biologics (Cayman) (HKG:2269) earnings and shareholder returns have been trending downwards for the last three years, but the stock ascends 9.4% this past week
Simply Wall St. · 02-15
WuXi Biologics (Cayman) (HKG:2269) earnings and shareholder returns have been trending downwards for the last three years, but the stock ascends 9.4% this past week - China's Healthcare Sector Could Ride the AI Wave -- Market TalkChina's Healthcare Sector Could Ride the AI Wave -- Market Talk
Dow Jones · 02-14
- China hawk to be picked for key US Commerce Dept job, sources sayChina hawk to be picked for key US Commerce Dept job, sources say
Reuters · 02-12
- Stock Track | Wuxi Biologics Soars 6.82% Intraday as UOB Kay Hian Upgrades to BuyStock Track | Wuxi Biologics Soars 6.82% Intraday as UOB Kay Hian Upgrades to Buy
Stock Track · 02-04
- UOB Kay Hian Upgrades Wuxi Biologics to Buy from Sell, Price Target is HK$23UOB Kay Hian Upgrades Wuxi Biologics to Buy from Sell, Price Target is HK$23
MT Newswires Live · 02-04
- WuXi Biologics (Cayman) Inc.'s (HKG:2269) P/E Is On The Mark
Simply Wall St. · 01-25
WuXi Biologics (Cayman) Inc.'s (HKG:2269) P/E Is On The Mark - Investor Confidence on WuXi Companies Seems Stronger -- Market TalkInvestor Confidence on WuXi Companies Seems Stronger -- Market Talk
Dow Jones · 01-20
- BUZZ-China's WuXi XDC rises on robust results forecastBUZZ-China's WuXi XDC rises on robust results forecast
Reuters · 01-15
- China Healthcare Sector to Get Policy Boost in 1Q -- Market TalkChina Healthcare Sector to Get Policy Boost in 1Q -- Market Talk
Dow Jones · 01-07
- WuXi Biologics (Cayman) Subsidiary to Sell Vaccines Manufacturing Facility in Ireland for $500 MillionWuXi Biologics (Cayman) Subsidiary to Sell Vaccines Manufacturing Facility in Ireland for $500 Million
MT Newswires Live · 01-07
- WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 MillionWuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million
Dow Jones · 01-07
- Wuxi Bio's Ireland Facility Sale Likely to Help With Cash Flow -- Market TalkWuxi Bio's Ireland Facility Sale Likely to Help With Cash Flow -- Market Talk
Dow Jones · 01-07
- Stock Track | WuXi Biologics Plummets 5.66% as Company Sells Irish Vaccine Facility Ahead of Potential U.S. RestrictionsStock Track | WuXi Biologics Plummets 5.66% as Company Sells Irish Vaccine Facility Ahead of Potential U.S. Restrictions
Stock Track · 01-07
- BUZZ-Hong Kong-listed WuXi Biologics falls as co sells Irish vaccine facilityBUZZ-Hong Kong-listed WuXi Biologics falls as co sells Irish vaccine facility
Reuters · 01-07
High
26.450
Open
26.150
Volume%
0.87
Low
25.450
Close
26.350
T/O Rate
0.30%
抱歉，当前请求异常(-1)
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email：uservice@ttm.financial